Literature DB >> 25234144

The role of airway epithelial cells and innate immune cells in chronic respiratory disease.

Michael J Holtzman1, Derek E Byers2, Jennifer Alexander-Brett2, Xinyu Wang2.   

Abstract

An abnormal immune response to environmental agents is generally thought to be responsible for causing chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Based on studies of experimental models and human subjects, there is increasing evidence that the response of the innate immune system is crucial for the development of this type of airway disease. Airway epithelial cells and innate immune cells represent key components of the pathogenesis of chronic airway disease and are emerging targets for new therapies. In this Review, we summarize the innate immune mechanisms by which airway epithelial cells and innate immune cells regulate the development of chronic respiratory diseases. We also explain how these pathways are being targeted in the clinic to treat patients with these diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25234144      PMCID: PMC4782595          DOI: 10.1038/nri3739

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  176 in total

1.  Lebrikizumab treatment in adults with asthma.

Authors:  Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal:  N Engl J Med       Date:  2011-08-03       Impact factor: 91.245

2.  Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells.

Authors:  Tamaki Okabayashi; Takashi Kojima; Tomoyuki Masaki; Shin-Ichi Yokota; Tadaatsu Imaizumi; Hiroyuki Tsutsumi; Tetsuo Himi; Nobuhiro Fujii; Norimasa Sawada
Journal:  Virus Res       Date:  2011-07-26       Impact factor: 3.303

3.  Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4.

Authors:  Valentine Ongeri Millien; Wen Lu; Joanne Shaw; Xiaoyi Yuan; Garbo Mak; Luz Roberts; Li-Zhen Song; J Morgan Knight; Chad J Creighton; Amber Luong; Farrah Kheradmand; David B Corry
Journal:  Science       Date:  2013-08-16       Impact factor: 47.728

Review 4.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

5.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.

Authors:  Jenny M Mjösberg; Sara Trifari; Natasha K Crellin; Charlotte P Peters; Cornelis M van Drunen; Berber Piet; Wytske J Fokkens; Tom Cupedo; Hergen Spits
Journal:  Nat Immunol       Date:  2011-09-11       Impact factor: 25.606

6.  IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop.

Authors:  Carine Bouffi; Mark Rochman; Christopher B Zust; Emily M Stucke; Andrey Kartashov; Patricia C Fulkerson; Artem Barski; Marc E Rothenberg
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

7.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.

Authors:  Derek E Byers; Jennifer Alexander-Brett; Anand C Patel; Eugene Agapov; Geoffrey Dang-Vu; Xiaohua Jin; Kangyun Wu; Yingjian You; Yael Alevy; Jean-Philippe Girard; Thaddeus S Stappenbeck; G Alexander Patterson; Richard A Pierce; Steven L Brody; Michael J Holtzman
Journal:  J Clin Invest       Date:  2013-08-15       Impact factor: 14.808

8.  Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations.

Authors:  Dara G Torgerson; Elizabeth J Ampleford; Grace Y Chiu; W James Gauderman; Christopher R Gignoux; Penelope E Graves; Blanca E Himes; Albert M Levin; Rasika A Mathias; Dana B Hancock; James W Baurley; Celeste Eng; Debra A Stern; Juan C Celedón; Nicholas Rafaels; Daniel Capurso; David V Conti; Lindsey A Roth; Manuel Soto-Quiros; Alkis Togias; Xingnan Li; Rachel A Myers; Isabelle Romieu; David J Van Den Berg; Donglei Hu; Nadia N Hansel; Ryan D Hernandez; Elliott Israel; Muhammad T Salam; Joshua Galanter; Pedro C Avila; Lydiana Avila; Jose R Rodriquez-Santana; Rocio Chapela; William Rodriguez-Cintron; Gregory B Diette; N Franklin Adkinson; Rebekah A Abel; Kevin D Ross; Min Shi; Mezbah U Faruque; Georgia M Dunston; Harold R Watson; Vito J Mantese; Serpil C Ezurum; Liming Liang; Ingo Ruczinski; Jean G Ford; Scott Huntsman; Kian Fan Chung; Hita Vora; Xia Li; William J Calhoun; Mario Castro; Juan J Sienra-Monge; Blanca del Rio-Navarro; Klaus A Deichmann; Andrea Heinzmann; Sally E Wenzel; William W Busse; James E Gern; Robert F Lemanske; Terri H Beaty; Eugene R Bleecker; Benjamin A Raby; Deborah A Meyers; Stephanie J London; Frank D Gilliland; Esteban G Burchard; Fernando D Martinez; Scott T Weiss; L Keoki Williams; Kathleen C Barnes; Carole Ober; Dan L Nicolae
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

9.  Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity.

Authors:  Lee A Albacker; Vinod Chaudhary; Ya-Jen Chang; Hye Young Kim; Ya-Ting Chuang; Muriel Pichavant; Rosemarie H DeKruyff; Paul B Savage; Dale T Umetsu
Journal:  Nat Med       Date:  2013-09-01       Impact factor: 53.440

10.  IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

Authors:  Jillian L Barlow; Samantha Peel; Jane Fox; Veera Panova; Clare S Hardman; Ana Camelo; Christine Bucks; Xiaoying Wu; Colleen M Kane; Daniel R Neill; Robin J Flynn; Ian Sayers; Ian P Hall; Andrew N J McKenzie
Journal:  J Allergy Clin Immunol       Date:  2013-06-27       Impact factor: 10.793

View more
  82 in total

1.  Genome-Wide Methylation Study Identifies an IL-13-induced Epigenetic Signature in Asthmatic Airways.

Authors:  Jessie Nicodemus-Johnson; Katherine A Naughton; Jyotsna Sudi; Kyle Hogarth; Edward T Naurekas; Dan L Nicolae; Anne I Sperling; Julian Solway; Steven R White; Carole Ober
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

2.  The impact of oil spill to lung health--Insights from an RNA-seq study of human airway epithelial cells.

Authors:  Yao-Zhong Liu; Astrid M Roy-Engel; Melody C Baddoo; Erik K Flemington; Guangdi Wang; He Wang
Journal:  Gene       Date:  2015-12-09       Impact factor: 3.688

3.  Regulatory role of Gpr84 in the switch of alveolar macrophages from CD11blo to CD11bhi status during lung injury process.

Authors:  Chengcong Yin; Long Cheng; Jiajia Pan; Lili Chen; Qi Xue; Juliang Qin; Shaoying Wang; Bing Du; Mingyao Liu; Ying Zhang; Wenzheng Jiang; Min Qian; Hua Ren
Journal:  Mucosal Immunol       Date:  2020-07-27       Impact factor: 7.313

4.  American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Authors:  Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

5.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

Review 6.  Dual oxidase: a novel therapeutic target in allergic disease.

Authors:  Albert van der Vliet; Karamatullah Danyal; David E Heppner
Journal:  Br J Pharmacol       Date:  2018-03-15       Impact factor: 8.739

7.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

8.  Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Authors:  Srirupa Chatterjee; Priya Luthra; Ekaterina Esaulova; Eugene Agapov; Benjamin C Yen; Dominika M Borek; Megan R Edwards; Anuradha Mittal; David S Jordan; Parameshwar Ramanan; Martin L Moore; Rohit V Pappu; Michael J Holtzman; Maxim N Artyomov; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

9.  Two interferon-independent double-stranded RNA-induced host defense strategies suppress the common cold virus at warm temperature.

Authors:  Ellen F Foxman; James A Storer; Kiran Vanaja; Andre Levchenko; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

10.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.